MedPath

TAIPEI MUNICIPAL WANFANG HOSPITAL (MANAGED BY TAIPEI MEDICAL UNIVERSITY)

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

189

Active:1
Completed:73

Trial Phases

5 Phases

Early Phase 1:1
Phase 2:3
Phase 3:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (82 trials with phase data)• Click on a phase to view related trials

Not Applicable
69 (84.1%)
Phase 4
6 (7.3%)
Phase 2
3 (3.7%)
Phase 3
3 (3.7%)
Early Phase 1
1 (1.2%)

Use of CBT-I Based Chatbot for Assisted Treatment in Patients With Insomnia

Not Applicable
Completed
Conditions
Insomnia
Depression/Anxiety
First Posted Date
2025-06-15
Last Posted Date
2025-06-15
Lead Sponsor
Taipei Medical University WanFang Hospital
Target Recruit Count
72
Registration Number
NCT07021625
Locations
🇨🇳

WanFang Hospital, Taipei City, Taiwan

Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea

Not Applicable
Recruiting
Conditions
Obstructive Sleep Apnea
First Posted Date
2025-03-06
Last Posted Date
2025-03-06
Lead Sponsor
Taipei Medical University WanFang Hospital
Target Recruit Count
100
Registration Number
NCT06862297
Locations
🇨🇳

Taipei Medical University WanFang Hospital, Taipei, Taiwan

Efficacy of NSAID Peritendinous Injection for Acute Tendinitis

Not Applicable
Active, not recruiting
Conditions
Tendinitis
Acute Tendonitis
NSAID (Non-Steroidal Anti-Inflammatory Drug)
Interventions
Drug: Peritendinous NSAID injection
Drug: Control group (placebo)
First Posted Date
2025-02-19
Last Posted Date
2025-02-19
Lead Sponsor
Taipei Medical University WanFang Hospital
Target Recruit Count
40
Registration Number
NCT06834425
Locations
🇨🇳

Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

AI-Driven Cognitive Digital Therapeutics for Dementia Management

Not Applicable
Recruiting
Conditions
Cognitive Impairment
First Posted Date
2025-01-20
Last Posted Date
2025-02-19
Lead Sponsor
Taipei Medical University WanFang Hospital
Target Recruit Count
30
Registration Number
NCT06783465
Locations
🇨🇳

Taipei Medical University Wan Fang Hospital, Taipei City, Taipei, Taiwan

A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

Phase 3
Not yet recruiting
Conditions
Tuberculosis, Pulmonary
First Posted Date
2024-07-29
Last Posted Date
2024-07-29
Lead Sponsor
Taipei Medical University WanFang Hospital
Target Recruit Count
100
Registration Number
NCT06526039
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 38
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.